Juan Pablo Frias
Chief Medical Officer and Head of Diabetes
Board Member
Earnings-call appearances
-
COVALENT-112: 52-Week Icovamenib Data in Type 1 Diabetes Conference Call2026-04-28
Biomea Fusion, Inc. (BMEA)